We Have Launched Drug Discovery Consulting Services

SO-002 investigator-initiated clinical trial: Subject enrollment completed

Research on Our Drug Candidate S-003 Published in an International Academic Journal

Participation in AACR2026: Poster presentation of our phosphorylation analysis results and assistance with exhibition booth for our phosphorylation analysis service

Kickoff meeting for investigator-initiated clinical trial of our 2nd therapeutic candidate for TDP43 protein-opathy was held

Our CEO’s Appointment as Specially Appointed Professor at Nanjing Medical University